Donor Muse Cell Treatment Without HLA-Matching Tests and Immunosuppressant TreatmentConcise Review Published on 2024-06-102024-09-05 Journal: Stem cells translational medicine [Category] update2024, [키워드] Amyotrophic lateral sclerosis epidermolysis bullosa immunotolerance Intravenous injection Myocardial infarction pluripotent sphingosine-1-phosphate stroke [DOI] 10.1093/stcltm/szae018 PMC 바로가기 [Article Type] Concise Review
The Implication of Sphingolipids in Viral InfectionsReview Published on 2023-12-092024-09-04 Journal: International Journal of Molecular Sciences [Category] 대상포진, [키워드] lipid metabolism sphingolipid metabolism sphingolipids sphingosine-1-phosphate viral infections [DOI] 10.3390/ijms242417303 PMC 바로가기 [Article Type] Review
Immune responses to SARS-CoV-2 vaccination in multiple sclerosis: a systematic review/meta-analysis다발성 경화증에서 SARS-CoV-2 백신 접종에 대한 면역 반응: 체계적인 검토/메타 분석Review Published on 2022-08-012022-09-11 Journal: Annals of Clinical and Translational Neurology [Category] COVID19(2023년), SARS, 치료기술, [키워드] Acetate Affect Alemtuzumab anti-CD20 Antibody detection Antibody Response Antibody responses Antibody testing applied CD20 cellular response Cellular responses Cladribine demonstrated dimethyl fumarate Epidemiology fumarate Glatiramer Glatiramer acetate Google Scholar HCs healthy control immune response Immunity inactivated independent interferon Interferon-beta mAb mAbs Meta-analysis meta-analysis and systematic review monoclonal antibody MOOSE mRNA mRNA vaccine mRNA vaccines multivariate logistic regression multivariate logistic regression model Natalizumab not affect observational studies observational study Odds ratio Patient positive predict response SARS-CoV-2 infections SARS-CoV-2 vaccination SARS-CoV-2 vaccine SARS-CoV-2 vaccines searched seroconversion rate seroconversion rates sphingosine-1-phosphate systematic review T cell T cell response T-cell Response T-cell responses Teriflunomide therapy Vaccine vaccine immunity vaccine response Vaccines vector virus [DOI] 10.1002/acn3.51628 PMC 바로가기 [Article Type] Review
Case report: Variant-specific pre-exposure prophylaxis of SARS-CoV-2 infection in multiple sclerosis patients lacking vaccination responses증례 보고: 백신 접종 반응이 없는 다발성 경화증 환자에서 SARS-CoV-2 감염의 변종 특이적 노출 전 예방Case Reports Published on 2022-07-252022-09-11 Journal: Frontiers in Immunology [Category] COVID19(2023년), MERS, SARS, 변종, 진단, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 anti-CD20 treatment antibody cocktail approved Asymptomatic Case report Case series case sery Casirivimab cilgavimab conducted coronavirus coronavirus disease coronavirus disease (COVID-19) COVID-19 infection develop dose European Evidence evidence of FIVE humoral Imdevimab immunomodulatory Immunotherapy impair incidence Infection Initially monoclonal monoclonal antibody multiple sclerosis Neutralizing Neutralizing activity Neutralizing antibodies neutralizing antibody offered omicron Omicron variant one patient pandemic Patient patients positive RT-PCR predominant prophylactic treatment Prophylaxis receptor reduced respiratory respiratory tract infection response retained Risk factors SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 pandemic SARS-CoV-2-neutralizing antibodies SARS-CoV-2-neutralizing antibody SARS-CoV-2-specific antibodies SARS-CoV-2-specific antibody severe acute respiratory syndrome Coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) severe adverse event severe adverse events Sotrovimab specific antibodies sphingosine sphingosine-1-phosphate sphingosine-1-receptor modulators (S1PR) sustained Symptom T-cell T-cells the patient the SARS-CoV-2 Tixagevimab Treatment union upper respiratory tract upper respiratory tract infection vaccination vaccination response variant were recorded [DOI] 10.3389/fimmu.2022.897748 PMC 바로가기 [Article Type] Case Reports
Response of COVID-19 vaccination in multiple sclerosis patients following disease-modifying therapies: A meta-analysis질병 조절 요법 후 다발성 경화증 환자에서 COVID-19 예방 접종의 반응: 메타 분석Meta-Analysis Published on 2022-07-012022-09-11 Journal: EBioMedicine [Category] COVID19(2023년), SARS, 바이오마커, 유전자 메커니즘, [키워드] addressed anti-CD20 anti-CD20 therapy anti-CD20 treatment association benefit booster dose CD20 cellular response Cochrane Library conducted COVID-19 COVID-19 vaccination COVID-19 vaccine COVID-19 vaccines Disease-modifying therapies Efficacy evaluate foundation humoral Humoral response IFN-β immune response literature medRxiv Meta-analysis Multiple multiple sclerosis natural no significant difference Odds ratio Odds ratios other treatment other treatments Patient random-effect receiving receptor required response response to vaccination risk SARS-CoV-2 vaccination SARS-CoV-2 vaccine SARS-CoV-2 vaccines Science Serologic response serological Shanghai significantly higher sphingosine sphingosine-1-phosphate suggested supported T-cell Response therapy Treatment vaccination was performed [DOI] 10.1016/j.ebiom.2022.104102 PMC 바로가기 [Article Type] Meta-Analysis
An Update on Sphingosine-1-Phosphate and Lysophosphatidic Acid Receptor Transcripts in Rodent Olfactory MucosaArticle Published on 2022-04-142023-07-08 Journal: International Journal of Molecular Sciences [Category] COVID19(2023년), [키워드] COVID lysophosphatidic acid Olfactory Mucosa receptors SARS-CoV-2 sphingosine-1-phosphate [DOI] 10.3390/ijms23084343 PMC 바로가기
Discordant humoral and T cell immune responses to SARS-CoV-2 vaccination in people with multiple sclerosis on anti-CD20 therapy항-CD20 요법을 받는 다발성 경화증 환자의 SARS-CoV-2 백신에 대한 체액 및 T 세포 면역 반응 불일치Article Published on 2021-11-012022-09-11 Journal: EBioMedicine [Category] MERS, SARS, 진단, 치료기술, [키워드] anti-CD20 anti-CD20 therapy array CD20 Cell Community COVID COVID-19 COVID-19 infection determine disease Donor donors generosity Genscript glycoprotein humoral Humoral immunity humoral immunity, multiple sclerosis, anti-CD20 therapies. Humoral response humoral responses IFN-γ IgG immune response immune responses immunoassay impair increase in incubated individual interferon gamma Johns Hopkins Johns Hopkins University linear models Mabtech Medicine mRNA vaccines multiple sclerosis participant PBMC PBMCs peptide peptides Plate receptor reduced Research robust SARS-CoV-2 SARS-CoV-2 vaccination School serum SFC Society Spectrum sphingosine sphingosine-1-phosphate spike glycoprotein subset supported T cell T cell response T cell responses T cells tested Therapies therapy translate [DOI] 10.1016/j.ebiom.2021.103636 PMC 바로가기 [Article Type] Article
The Anti-Infectious Role of Sphingosine in Microbial DiseasesReview Published on 2021-05-042022-10-31 Journal: Cells [Category] COVID-19, SARS, [키워드] acute respiratory syndrome airway epithelial cell Bacteria Bacterial Bacterial infections bacterial pathogen Cancer Cell cellular ceramide cholesterol component Coronavirus-2 death Defense Diseases fibrosis functions fungal pathogens fungi herpes simplex host cell receptor HSV-1 Infection Inflammation inhibit involved kill macrophages membrane metabolite microbes normalized organized Pathogenesis Prevent promote recent reduced released respiratory tract role SARS-CoV-2 shown signaling molecule sphingolipid sphingolipids sphingosine sphingosine kinases sphingosine-1-phosphate subsequent viral infection viral spike protein virus viruses [DOI] 10.3390/cells10051105 PMC 바로가기 [Article Type] Review
Host sphingolipids: Perspective immune adjuvant for controlling SARS-CoV-2 infection for managing COVID-19 disease숙주 스핑고지질: COVID-19 질병 관리를 위한 SARS-CoV-2 감염 제어를 위한 관점 면역 보조제Review Published on 2021-02-012022-09-11 Journal: Prostaglandins & other lipid mediators [Category] SARS, 신약개발, 치료제, [키워드] Activation Antigen presentation Antiviral approach autophagy Bacterial infections ceramide clearance COVID 19 COVID-19 cases COVID-19 disease COVID-19 infection COVID-19 patients derivative effector immune response enzyme II epithelial cell epithelial cells expected Features fibrosis fingolimod FTY720 Host host-pathogen interactions human diseases hyper-inflammatory response Hyper-inflammatory responses IL-6 immune Immune adjuvants immune responses immunosuppressive Infection involved Lipid Lyase M1/M2 macrophages macrophages membrane-bound modulate Pathogenesis pathological outcomes pathological response phosphate promote receptor Replication respiratory SARS-CoV-2 SARS-COV-2 infection Signaling sphingolipid sphingolipids sphingosine-1-phosphate symptomatic T cell T cell response Th1 Th1 effector response. [DOI] 10.1016/j.prostaglandins.2020.106504 PMC 바로가기 [Article Type] Review
Targeting the SphK-S1P-SIPR Pathway as a Potential Therapeutic Approach for COVID-19Review Published on 2020-09-292022-10-29 Journal: International Journal of Molecular Sciences [Category] COVID-19, SARS, [키워드] acute respiratory syndrome alleviate Blood Brain catastrophic clinical trial cognate receptor Complication complications coronavirus COVID-19 COVID-19 symptom death disease drug Effect evaluated Evidence G-protein-coupled receptors Health help hyperinflammation Hyperinflammatory immune response in viral key factor life-threatening major coronavirus MERS-CoV Middle East modulation Multiorgan dysfunction neurological Outbreaks pandemic pathway phosphate Potential provide Psychiatric receptor receptors Replication respiratory Respiratory tract infections SARS-CoV-1 SARS-CoV-2 SARS-COV-2 infection Septic shock severe COVID-19 symptom Spanish flu sphingosine Sphingosine kinase sphingosine-1-phosphate symptoms of COVID-19 syndrome targeting therapy Thrombotic complications Vaccine Vaccines Vascular Vascular endothelium vasculature viral replication [DOI] 10.3390/ijms21197189 PMC 바로가기 [Article Type] Review